How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificity

泛素携带酶如何促进泛素连接酶特异性

基本信息

  • 批准号:
    10583496
  • 负责人:
  • 金额:
    $ 35.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

The reversible control of enzyme activity is one of the cornerstone features enabling life. Cycles of protein phosophorylation and de-phosphorylation have been appreciated for decades to regulate enzymes, and the pharmacological inhibition of protein kinases and phosphatases has furnished a biotech industry intent on treating various human diseases for nearly as long. One major drawback to this strategy is that the enzymes that regulate protein phosphorylation represent perhaps 5 % of the human proteome, such that the vast majority of aberrant proteins responsible for human disease have remained undruggable. More recently, drugs have been invented that induce proximity between a disease-causing protein and an enzyme called a ubiquitin ligase that promotes the destruction of the problematic protein. Indeed, this new drug modality is feeding a billion dollar per year industry push to employ ubiquitin ligases to treat various human diseases including breast and prostate cancers as well as multiple myeloma, to name a few. Most of these efforts have been utilizing a family of enzymes called the Cullin-RING ligases (CRLs). With some 200 members in humans, the CRLs collectively control approximately 20 % of ubiquitin-dependent protein degradation in cells. As such, an appreciation for how these enzymes are regulated is of considerable interest to a wide audience from the scientific community. Similar to the paradigm of protein phosphorylation, the control of CRLs is believed to be determined predominantly through their reversible modification with a protein called NEDD8. And while human CRLs are known to partner with at least 7 additional enzymes, which we refer to as ubiquitin-carrying enzymes (UCEs), that help promote CRL- dependent protein substrate degradation, it also was believed that UCEs act promiscuously towards CRLs which would preclude CRL regulation at the level of CRL-UCE interaction. However, CRL-UCE specificity is strongly implied by the recent structure of an active CRL. Preliminary results here indicate that CRL-UCE specificity endows these pairs with exceptionally rapid rates of ubiquitin transfer and with the capability of producing CRL substrates modified with unique poly-ubiquitin chain architectures, potentially providing an additional layer of control of CRL function beyond neddylation. In consideration of these observations, this application seeks to test the hypothesis that UCEs generally display specificity for CRL-substrate complexes, and that the biological purpose of these specific CRL-UCE pairs is to both enhance the rates of ubiquitin transfer from UCEs to CRL substrates as well as to uniquely code the poly-ubiquitin chain to promote outcomes including protein degradation or localization. The proposed studies will explore an entirely novel area of CRL biology, the specificity of UCEs for CRLs, utilizing proteomic and cell biological assays to complement a powerful, quantitative kinetics platform. These studies will illuminate how CRL activities are regulated and support a new drug modality that harnesses the power of CRLs to degrade disease-causing proteins.
酶活性的可逆控制是使生命得以存在的基石特征之一。蛋白质循环 几十年来,磷酸化和去磷酸化已经被理解为调节酶, 蛋白激酶和磷酸酶的药理学抑制提供了生物技术工业, 治疗各种人类疾病的时间几乎一样长这种策略的一个主要缺点是, 调节蛋白质磷酸化的蛋白质可能占人类蛋白质组的5%,因此, 导致人类疾病的异常蛋白质仍然是不可治疗的。最近,药物已经 发明了一种诱导致病蛋白和一种叫做泛素连接酶的酶之间接近的方法, 促进有问题的蛋白质的破坏。事实上,这种新的药物模式正在为每个人提供10亿美元的资金。 2004年,业界推动利用泛素连接酶治疗各种人类疾病,包括乳腺癌和前列腺疾病 癌症以及多发性骨髓瘤,仅举几例。这些努力中的大多数都是利用酶家族 称为Cullin-RING连接酶(CRL)。在人类中有大约200个成员, 细胞中大约20%的泛素依赖性蛋白降解。因此,欣赏这些 酶的调节是科学界广泛关注的问题。类似于 在蛋白质磷酸化的范例中,CRL的控制被认为主要通过以下方式来确定: 它们被一种叫做NEDD 8的蛋白质可逆地修饰。虽然人类CRL已知与 至少7种额外的酶,我们称之为泛素携带酶(UCEs),有助于促进CRL- 依赖于蛋白质底物降解,还认为UCE对CRL作用混杂, 将在CRL-UCE交互水平上排除CRL监管。然而,CRL-UCE特异性强, 由活动CRL的最新结构暗示。初步结果表明,CRL-UCE特异性 赋予这些对非常快的泛素转移速率和产生CRL的能力, 用独特的多聚泛素链结构修饰的基底,潜在地提供了一个额外的 控制CRL功能,超越neddylation。考虑到这些观察结果,本申请寻求测试 假设UCE通常显示对CRL-底物复合物的特异性, 这些特定CRL-UCE对的目的是提高泛素从UCE转移到CRL的速率 底物以及独特编码多聚泛蛋白链以促进包括蛋白质在内的结果 降解或定位。拟议的研究将探索CRL生物学的一个全新领域, UCE对CRL的特异性,利用蛋白质组学和细胞生物学测定来补充强大的定量 动力学平台这些研究将阐明CRL活动是如何调节的,并支持一种新的药物模式 利用CRL的力量来降解致病蛋白质。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary L. Kleiger其他文献

Gary L. Kleiger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary L. Kleiger', 18)}}的其他基金

Identification of small molecule inhibitors of the DDI2 protease
DDI2 蛋白酶小分子抑制剂的鉴定
  • 批准号:
    10638837
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificity
泛素携带酶如何促进泛素连接酶特异性
  • 批准号:
    10180287
  • 财政年份:
    2021
  • 资助金额:
    $ 35.32万
  • 项目类别:
How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificity
泛素携带酶如何促进泛素连接酶特异性
  • 批准号:
    10783452
  • 财政年份:
    2021
  • 资助金额:
    $ 35.32万
  • 项目类别:
How ubiquitin-carrying enzymes contribute to ubiquitin ligase specificity
泛素携带酶如何促进泛素连接酶特异性
  • 批准号:
    10396039
  • 财政年份:
    2021
  • 资助金额:
    $ 35.32万
  • 项目类别:
Function of the Six ATPases in the Yeast 19S Particle
酵母 19S 颗粒中六种 ATP 酶的功能
  • 批准号:
    7060314
  • 财政年份:
    2005
  • 资助金额:
    $ 35.32万
  • 项目类别:
Function of the Six ATPases in the Yeast 19S Particle
酵母 19S 颗粒中六种 ATP 酶的功能
  • 批准号:
    6935767
  • 财政年份:
    2005
  • 资助金额:
    $ 35.32万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了